INSULIN RESISTANCE AFFECTS THE THERAPEUTIC EFFECT OF FERTILITY-SPARING TREATMENT IN PATIENTS WITH ENDOMETRIAL ATYPICAL HYPERPLASIA

被引：0
|
作者：
Yang, B. [1 ]
Chen, X. [1 ]
Luo, X. [1 ]
Cheng, Y.
Shan, W. [1 ]
机构：
[1] Gynecol Dept, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0312
引用
收藏
页码：1286 / 1286
页数：1
相关论文
共 50 条
  • [31] Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy
    De Marzi, Patrizia
    Bergamini, Alice
    Luchini, Stefania
    Petrone, Micaela
    Taccagni, Gian Luca
    Mangili, Giorgia
    Colombo, Gabriella
    Candiani, Massimo
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2015, 22 (07) : 1178 - 1182
  • [32] Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
    Ding, Yingqiao
    Fan, Yuan
    Li, Xingchen
    Wang, Yiqin
    Wang, Jianliu
    Tian, Li
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2022, 20 (01)
  • [33] Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
    Yingqiao Ding
    Yuan Fan
    Xingchen Li
    Yiqin Wang
    Jianliu Wang
    Li Tian
    [J]. Reproductive Biology and Endocrinology, 20
  • [34] Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience
    Shikeli, Sumaya
    Gowri, Vaidyanathan
    Al Rawahi, Thuria
    [J]. JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2020, 24 (04): : 466 - 469
  • [35] Progression of fertility-sparing treatment for atypical endometrial hyperplasia in a woman with lynch syndrome: a case report and review of the literature
    Hsu, Ya-Ting
    Chen, Chi-Hau
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [36] Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study
    Yiqin Wang
    Rong Zhou
    Xiaobo Zhang
    Huixin Liu
    Danhua Shen
    Jianliu Wang
    [J]. BMC Women's Health, 21
  • [37] Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study
    Wang, Yiqin
    Zhou, Rong
    Zhang, Xiaobo
    Liu, Huixin
    Shen, Danhua
    Wang, Jianliu
    [J]. BMC WOMENS HEALTH, 2021, 21 (01)
  • [38] A phase II study of medroxyprogesterone acetate plus metformin as fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.
    Mitsuhashi, Akira
    Usui, Hirokazu
    Satoh, Yasunori
    Kiyokawa, Takako
    Shozu, Makio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer
    Gonthier, Clementine
    Walker, Francine
    Luton, Dominique
    Yazbeck, Chadi
    Madelenat, Patrick
    Koskas, Martin
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 133 (01) : 33 - 37
  • [40] EFFECT OF MEGESTROL ACETATE PLUS METFORMIN AS FERTILITY-SPARING TREATMENT FOR PATIENTS WITH ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CANCER. A RANDOMIZED CONTROLLED TRIAL
    Yang, B.
    Yierfulati, G.
    Guan, J.
    Chen, X.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A4 - A5
12345